GO
Loading...

Cramer Talks Biotech With ImmunoGen CEO

Monday, 10 Dec 2012 | 6:15 PM ET

Dan Junius, ImmunoGen CEO, discusses which drugs are in the company's pipeline, and weighs in on the outlook for the company, with Mad Money's Jim Cramer.